Skip to content

uniQure QURE Net margin

Net margin at other companies

Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-90.9%-2.1pp
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
-33,121.9%-33,159pp
PTC Therapeutics logo
PTC TherapeuticsPTCT
42.3%+27.4pp
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
-13,856.5%-15,058pp
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
53.9%+16.7pp
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-125.9%-54.5pp

Other financials

Income statement

See full
Revenue$3.6M+127%
Gross profit$3.3M+144%
Operating income-$45.7M-16.2%
Net income-$53.5M-22.7%
EPS (diluted)-$0.85-3.7%

Balance sheet

See full
Cash & equivalents$140.0M-35.6%
Total debt$63.3M-4.3%
Total equity$149.3M+343%
Total assets$778.7M+28.6%

Cash flow

See full
Operating cash flow-$38.2M+13.3%
CapEx$140.0K+11.1%
Free cash flow-$38.4M+13.2%

Valuation

See full
Market cap$3.09B+78.4%
Enterprise value$3.02B+124%
P/S170.9×+85.1×

Profitability

See full
Gross margin90.6%-2.9pp
Operating margin-1,059.7%+380pp
FCF margin-953.7%+169pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.4×-1.5×
Current ratio10.4×-1.6×

Where this comes from

Calculated from uniQure’s reported figures.

Based on trailing twelve months.

The official record: uniQure’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about uniQure's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is uniQure's net margin?
uniQure (QURE) reported net margin of -1,154.4% in Q1 2026.
How has uniQure's net margin changed year-over-year?
uniQure's net margin decreased by 7.2% year-over-year, from -1,077.1% to -1,154.4%.
What is the long-term trend for uniQure's net margin?
Over 5 years (2020 to 2025), uniQure's net margin has grown at a 30.0% compound annual growth rate (CAGR), from -333.3% to -1,236%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.